Cargando…

Antibiotic surveillance on a paediatric intensive care unit: easy attainable strategy at low costs and resources

BACKGROUND: Antibiotic surveillance is mandatory to optimise antibiotic therapy. Our objectives were to evaluate antibiotic use in our pediatric intensive care unit (PICU) and to implement a simple achievable intervention aimed at improving antibiotic therapy. METHOD: Prospective, 3 months surveilla...

Descripción completa

Detalles Bibliográficos
Autores principales: Stocker, Martin, Ferrao, Eduardo, Banya, Winston, Cheong, Jamie, Macrae, Duncan, Furck, Anke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534515/
https://www.ncbi.nlm.nih.gov/pubmed/23259701
http://dx.doi.org/10.1186/1471-2431-12-196
_version_ 1782475345466753024
author Stocker, Martin
Ferrao, Eduardo
Banya, Winston
Cheong, Jamie
Macrae, Duncan
Furck, Anke
author_facet Stocker, Martin
Ferrao, Eduardo
Banya, Winston
Cheong, Jamie
Macrae, Duncan
Furck, Anke
author_sort Stocker, Martin
collection PubMed
description BACKGROUND: Antibiotic surveillance is mandatory to optimise antibiotic therapy. Our objectives were to evaluate antibiotic use in our pediatric intensive care unit (PICU) and to implement a simple achievable intervention aimed at improving antibiotic therapy. METHOD: Prospective, 3 months surveillance of antibiotic use on PICU (phase I) and evaluation according to the CDC 12-step campaign with development of an attainable intervention. 3 months surveillance (phase II) after implementation of intervention with comparison of antibiotic use. RESULTS: Appropriate antibiotic use for culture-negative infection-like symptoms and targeted therapy for proven infections were the main areas for potential improvement. The intervention was a mandatory checklist requiring indication and recording likelihood of infection at start of antibiotic therapy and a review of the continuing need for therapy at 48 h and 5 days, reasons for continuation and possible target pathogen. The percentage of appropriate empiric antibiotic therapy courses for culture-negative infection-like symptoms increased from 18% (10/53) to 74% (42/57; p<0.0001), duration of therapy <3 days increased from 18% (10/53) to 35% (20/57; p=0.05) and correct targeting of pathogen increased from 58% (7/12) to 83% (20/24; p=0.21). CONCLUSIONS: Antibiotic surveillance using the CDC 12-step campaign can help to evaluate institutional antibiotic therapy. Development of an attainable intervention using a checklist can show improved antibiotic use with minimal expense.
format Online
Article
Text
id pubmed-3534515
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35345152013-01-03 Antibiotic surveillance on a paediatric intensive care unit: easy attainable strategy at low costs and resources Stocker, Martin Ferrao, Eduardo Banya, Winston Cheong, Jamie Macrae, Duncan Furck, Anke BMC Pediatr Research Article BACKGROUND: Antibiotic surveillance is mandatory to optimise antibiotic therapy. Our objectives were to evaluate antibiotic use in our pediatric intensive care unit (PICU) and to implement a simple achievable intervention aimed at improving antibiotic therapy. METHOD: Prospective, 3 months surveillance of antibiotic use on PICU (phase I) and evaluation according to the CDC 12-step campaign with development of an attainable intervention. 3 months surveillance (phase II) after implementation of intervention with comparison of antibiotic use. RESULTS: Appropriate antibiotic use for culture-negative infection-like symptoms and targeted therapy for proven infections were the main areas for potential improvement. The intervention was a mandatory checklist requiring indication and recording likelihood of infection at start of antibiotic therapy and a review of the continuing need for therapy at 48 h and 5 days, reasons for continuation and possible target pathogen. The percentage of appropriate empiric antibiotic therapy courses for culture-negative infection-like symptoms increased from 18% (10/53) to 74% (42/57; p<0.0001), duration of therapy <3 days increased from 18% (10/53) to 35% (20/57; p=0.05) and correct targeting of pathogen increased from 58% (7/12) to 83% (20/24; p=0.21). CONCLUSIONS: Antibiotic surveillance using the CDC 12-step campaign can help to evaluate institutional antibiotic therapy. Development of an attainable intervention using a checklist can show improved antibiotic use with minimal expense. BioMed Central 2012-12-21 /pmc/articles/PMC3534515/ /pubmed/23259701 http://dx.doi.org/10.1186/1471-2431-12-196 Text en Copyright ©2012 Stocker et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Stocker, Martin
Ferrao, Eduardo
Banya, Winston
Cheong, Jamie
Macrae, Duncan
Furck, Anke
Antibiotic surveillance on a paediatric intensive care unit: easy attainable strategy at low costs and resources
title Antibiotic surveillance on a paediatric intensive care unit: easy attainable strategy at low costs and resources
title_full Antibiotic surveillance on a paediatric intensive care unit: easy attainable strategy at low costs and resources
title_fullStr Antibiotic surveillance on a paediatric intensive care unit: easy attainable strategy at low costs and resources
title_full_unstemmed Antibiotic surveillance on a paediatric intensive care unit: easy attainable strategy at low costs and resources
title_short Antibiotic surveillance on a paediatric intensive care unit: easy attainable strategy at low costs and resources
title_sort antibiotic surveillance on a paediatric intensive care unit: easy attainable strategy at low costs and resources
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534515/
https://www.ncbi.nlm.nih.gov/pubmed/23259701
http://dx.doi.org/10.1186/1471-2431-12-196
work_keys_str_mv AT stockermartin antibioticsurveillanceonapaediatricintensivecareuniteasyattainablestrategyatlowcostsandresources
AT ferraoeduardo antibioticsurveillanceonapaediatricintensivecareuniteasyattainablestrategyatlowcostsandresources
AT banyawinston antibioticsurveillanceonapaediatricintensivecareuniteasyattainablestrategyatlowcostsandresources
AT cheongjamie antibioticsurveillanceonapaediatricintensivecareuniteasyattainablestrategyatlowcostsandresources
AT macraeduncan antibioticsurveillanceonapaediatricintensivecareuniteasyattainablestrategyatlowcostsandresources
AT furckanke antibioticsurveillanceonapaediatricintensivecareuniteasyattainablestrategyatlowcostsandresources